Next Article in Journal
Comparative and Phylogenetic Analysis of Complete Chloroplast Genomes in Leymus (Triticodae, Poaceae)
Next Article in Special Issue
Missense Variants in GFRA1 and NPNT Are Associated with Congenital Anomalies of the Kidney and Urinary Tract
Previous Article in Journal
Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes
Previous Article in Special Issue
A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma
 
 
Article
Peer-Review Record

Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients

Genes 2022, 13(8), 1424; https://doi.org/10.3390/genes13081424
by Lena Rutkowska 1, Iwona Pinkier 1, Kinga Sałacińska 1, Łukasz Kępczyński 1, Dominik Salachna 1, Joanna Lewek 2,3, Maciej Banach 2,3,4, Paweł Matusik 5, Ewa Starostecka 6, Andrzej Lewiński 6,7, Rafał Płoski 8, Piotr Stawiński 8 and Agnieszka Gach 1,*
Reviewer 1:
Reviewer 2:
Genes 2022, 13(8), 1424; https://doi.org/10.3390/genes13081424
Submission received: 18 July 2022 / Revised: 6 August 2022 / Accepted: 8 August 2022 / Published: 10 August 2022
(This article belongs to the Special Issue Genetic and Molecular Basis of Inherited Disorders)

Round 1

Reviewer 1 Report

The authors aimed of to identify novel CNV changes in FH patients without detected pathogenic SNVs using targeted sequencing and evaluation of CNV calling tool (DECoN) working on gene panel NGS data in a group of 136 adult and child patients with possible FH. They also assessed its suitability as a screening step in genetic diagnostics. To test the DECoN program, the whole study group was referred for bioinformatic analysis. The DECoN program detected duplication of exons 4-8 in the LDLR gene in two patients, whose genetic analysis was stopped after the NGS step. The integration of the two methods proved to be particularly valuable in a five-year-old girl presenting with extreme hypercholesterolemia, with both a pathogenic missense variant (c.1747C>T) and exons 9-10 deletion in LDLR. This is the first report of a heterozygous deletion of exons 9 and 10 co-occurring with SNV. They concluded that the NGS-based approach has the potential to identify large-scale variation in the LDLR gene and could be further applied to extend CNV screening in other FH-related genes. Nevertheless, the outcomes from the bioinformatic approach still need to be confirmed by MLPA; hence, the latter remains the reference method for assessing CNV in FH patients.

It is a well designed and nicely presented study presenting very important novel data on screening of CNV changes in FH patients.

 

Comments:

·       1. Some clinical consequences, especially therapeutic difficulties in these severe cases could be mentioned.

·       2. The relatively low number of patients with CNV changes is obvious, it should be mentioned as a limitation of the study.

·       3. The figure legend of Fig 1, especially Fig1C-E should be completed.  

·       4.   The reference style is not appropriate.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

congratulations for the this scientific effort to address the essential part of resrch

Methodology can be improved not necessarily 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop